TIL-ACT After NMA Chemo with IL-2 and Nivo Rescue in Metastatic Melanoma (mMEL)
Clinical trial NCT03475134 · COMPLETED
Trial details
- NCT number
- NCT03475134
- Sponsor
- Centre Hospitalier Universitaire Vaudois
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-21
- Primary completion
- 2021-02-09
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.